Akero Therapeutics, Inc. Banner Image

Akero Therapeutics, Inc.

  • Ticker AKRO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Akero Therapeutics, Inc. Logo Image
  • 11-50 Employees
  • Based in South San Francisco, California
Akero is a cardio-metabolic NASH company dedicated to reversing the escalating NASH epidemic by developing pioneering medicines designed to restore metabolic balance and improve overall health of NASH patients. The Company's lead product candidate, efruxifermin, has been evaluated in a 16-week Phase 2a clinical trial, the BALANCED study. Akero Therapeutics is headquartered in South SanMore Francisco, CA.
4.8 / 5.0 (198)

Akero Therapeutics, Inc. reports have an aggregate usefulness score of 4.8 based on 198 reviews.

Akero Therapeutics, Inc.

Most Recent Annual Report

Akero Therapeutics, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Akero Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!